Byju’s lenders scrap talks to recast $1.2B loan; Janus Henderson cuts PharmEasy valuation further to…
Byju’s woes seem to have no end. The company has suffered a series of setbacks over the last year, including ED raids and valuation markdowns. Now, lenders have halted talks with the edtech major to restructure a $1.2 billion loan. This and…